For Immediate Release

Premier to broaden clinician access to Forward Science’s FDA-cleared, non-drug oral wound dressing for post-procedural periodontal care

Plymouth Meeting, PA August 14, 2026 – Premier^® Dental Products Company, a global leader in innovative dental consumables and clinical solutions, today announced an exclusive distribution partnership with Forward Science to bring PerioStōm^®, an FDA-cleared, non-drug oral wound dressing, to dental professionals throughout the United States. Through this partnership, Premier will serve as the exclusive distributor of PerioStōm^®, expanding access to a science-driven solution designed to support healing and patient comfort following periodontal procedures.

The addition of PerioStōm^® reinforces Premier’s commitment to delivering innovative technologies that improve clinical outcomes and enhance everyday dental practice. By leveraging Premier’s professional dental network, clinicians will have greater access to a novel post-procedural care solution that integrates into existing periodontal treatment protocols.

PerioStōm^® is powered by chitosan microspheres, a biocompatible polymer. Applied directly into the periodontal pocket, PerioStōm^® forms a protective, bio-adhesive barrier intended to help protect vulnerable tissue from irritation and trauma while supporting gingival healing and patient comfort while fitting seamlessly into existing periodontal treatment protocols, such as scaling and root planing (SRP). The delivery system is designed for consistent placement and integration into standard clinical workflows.

“Premier is committed to identifying and delivering clinically meaningful innovations that help dental professionals improve patient care. PerioStōm^® represents a unique advancement in post-procedural periodontal care, offering clinicians an FDA-cleared, non-drug solution that supports healing while fitting naturally into existing treatment protocols. We are excited to partner with Forward Science to make this innovative technology more broadly available to dental professionals across the country.”

— Perry Lowe, CEO, Premier Dental Products Company

Developed over several years of research and innovation, PerioStōm^® represents a significant advancement in periodontal therapy. As exclusive distributor, Premier will work closely with Forward Science to support product commercialization and clinician education while expanding awareness and adoption nationwide.

“This collaboration with Premier strengthens the pathway for PerioStōm^® through a trusted partner in the dental industry,” said Robert J. Whitman, CEO of Forward Science. “Together, we are focused on bringing what we believe is one of the most impactful advancements the periodontal therapy field has seen in decades to clinicians nationwide, helping improve patient care and change more lives.”

The partnership is expected to broaden availability of PerioStōm^® to a wider audience of dental professionals, supporting a more proactive approach to post-procedural periodontal care through an effective, non-drug solution designed for everyday clinical use.

For more information about PerioStōm^®, visit PerioStom.com.